Irisin a Novel Metabolic Biomarker: Present Knowledge and Future Directions
The rising prevalence of chronic diseases such as type 2 diabetes and cardiovascular diseases owing to fat mass excess has been described. In recent years, muscle function/dysfunction has become relevant in metabolic homeostasis. Irisin was described as an exercise-induced myokine. It is the product...
Saved in:
Main Authors: | Ilse Yessabel Martinez Munoz, Eneida del Socorro Camarillo Romero, Jose de Jesus Garduno Garcia |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2018/7816806 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effect of Irisin as a Metabolic Regulator and Its Therapeutic Potential for Obesity
by: Hui Li, et al.
Published: (2021-01-01) -
Expression and Function of Synthetic Dimeric Exercise-Induced Cytokine Irisin-Irisin
by: LIU Fengying, et al.
Published: (2023-02-01) -
Metabolic Profile in a Cohort of Young Sicilian Patients with Klinefelter’s Syndrome: The Role of Irisin
by: Stefano Radellini, et al.
Published: (2022-01-01) -
Relationship of serum irisin levels, physical activity, and metabolic syndrome biomarkers in obese individuals with low-calorie intake and non-obese individuals with high-calorie intake
by: Jalal Hejazi, et al.
Published: (2025-01-01) -
Association between Irisin, hs-CRP, and Metabolic Status in Children and Adolescents with Type 2 Diabetes Mellitus
by: Leticia Elizondo-Montemayor, et al.
Published: (2019-01-01)